Laura Elizabeth Lansdowne
Managing Editor
As managing editor, Laura works closely with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She plays an active part in the general oversight and training of the in-house editorial team, as well as working directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.
Latest Content
Infographic
Cancer Epigenetics
Today, there is growing evidence that in various diseases, including different types of cancer, there are underlying epigenetic mechanisms at play. Download this infographic to explore various epigenetic mechanisms in cancer.
News
New Non-Lethal Method To Study Scorpion Venom
Researchers have discovered a non-lethal way to study scorpion venom genes by triggering the emptying of the animal’s venom glands using electrostimulation. The study was published in PLOS ONE.
Article
Team Reverses the Clinical Signs of Alzheimer’s Disease in Mice
In a study published in Genome Medicine, Dr. Patrick Aloy, head of the structural bioinformatics and network biology laboratory at IRB Barcelona and colleagues report that they have successfully reversed the clinical signs of Alzheimer's disease in mice by repurposing four existing drugs that are currently approved to treat high blood pressure and inflammation.
Article
Identifying Novel Drug Targets for Neurodegeneration
During this year’s ELRIG Drug Discovery Meeting, Prof. Paul Brennan from the University of Oxford, discussed recent progress to develop drug compounds against novel targets in neuroinflammatory and sub-cellular organelle dysfunction pathways.
Podcast
Opinionated Science Episode 37: Finding Answers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Mesothelioma
In this podcast, the team look at two overlooked diseases. Malignant mesothelioma was known to be caused by the construction material asbestos decades before it was banned, while ME/CFS remains poorly understood by science. Two new developments could bring and clarity and a route to better treatment for these conditions.
Article
The Role of Neuropilin-1 in SARS-CoV-2 Infection
Dr. Maria Anastasina from the University of Helsinki and colleagues have been investigating the involvement of neuropilin-1 in SARS-CoV-2 cell entry and infectivity. Technology Networks had the pleasure of speaking with Anastasina to learn more about this work.
Article
Reconnecting at ELRIG Drug Discovery 2021
Technology Networks is delighted to be reporting – in person – from The European Laboratory Research & Innovation Group (ELRIG)'s Drug Discovery 2021 meeting. In this article, we explore the key themes discussed in the meeting's opening address.
Article
Uncovering Key Interactions Between Cancer-Driving Proteins
Research conducted as part of the Cancer Cell Map Initiative (CCMI), has revealed interactions between cancer-driving proteins, that were unknown, until now. Findings were published in three separate papers in Science.
Industry Insight
Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows
In recent years, a number of new cell and gene therapies have been developed to treat a variety of indications, including cancer and inherited retinal dystrophies. While these therapies have proven to be beneficial to patients, their scalability and manufacturability are two enduring challenges. Technology Networks spoke to Tara St.Amand, PhD, MBA, director of business technology, bioprocess at Corning to learn more about the key challenges faced when scaling up the manufacturing of cell products.
Infographic
Spatial Biology
Download this infographic to discover how spatial biology can elucidate biological activity in relation to environment, is utilized in neuroscience and cancer research, and can be explored using various technologies.
Advertisement
